Raaj Medisafe India Ltd
Fundamental Score
Raaj Medisafe India Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of RAAJMEDI across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (32.48%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (15.02%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Attractive Valuation (P/E: 11.80 vs Industry: 21.55)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Robust Profit Growth (78.35%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Revenue Growth (68.65%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (23.42% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Excellent EPS Growth (47.93% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (72.62% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Balanced Promoter Holding (73.80%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
5 factors identified
Elevated Debt Levels (D/E: 1.79)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability and cash flow generation.
Negative Free Cash Flow (₹-21.19 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
High Debt-to-Equity Ratio
Observation: Elevated financial risk due to high leverage.
Analysis: High debt levels may strain cash flows and increase financial risk during economic downturns.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Raaj Medisafe India Ltd
About RAAJMEDI
Business Overview
Raaj Medisafe India Limited manufactures and sells disposable hygiene products, HDPE containers, PP closures and plastic liners for packaging of goods, and aluminum crown caps in India. The company operates through two segments, Plastic and Hygiene. It offers caps and plugs, plastic bottles, and aluminum caps. The company also offers sanitary pads, maternity pads, baby diapers and panty liners. In addition, it offers aluminium and VCI bags, plastic rolls; and food grade and DMF certified poly bags and sheets. The company was formerly known as Manoj Surgical Industries Limited. Raaj Medisafe India Limited was incorporated in 1985 and is based in Ujjain, India.
Company Details
Key Leadership
Corporate Events
RAAJMEDI Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Raaj Medisafe India Ltd (RAAJMEDI)?
As of 29 Jan 2026, 10:33 am IST, Raaj Medisafe India Ltd (RAAJMEDI) is currently trading at ₹88.17. The stock has a market capitalization of ₹90.83 (Cr).
Is RAAJMEDI share price Overvalued or Undervalued?
RAAJMEDI is currently trading at a P/E ratio of 11.80x, compared to the industry average of 21.55x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Raaj Medisafe India Ltd share price?
Key factors influencing RAAJMEDI's price include its quarterly earnings growth (Sales Growth: 68.65%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Raaj Medisafe India Ltd a good stock for long-term investment?
Raaj Medisafe India Ltd shows a 5-year Profit Growth of 72.62% and an ROE of 32.48%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 1.79 before investing.
How does Raaj Medisafe India Ltd compare with its industry peers?
Raaj Medisafe India Ltd competes with major peers in the Packaging. Investors should compare RAAJMEDI's P/E of 11.80x and ROE of 32.48% against the industry averages to determine its competitive standing.
What is the P/E ratio of RAAJMEDI and what does it mean?
RAAJMEDI has a P/E ratio of 11.80x compared to the industry average of 21.55x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹12 for every ₹1 of annual earnings.
How is RAAJMEDI performing according to Bull Run's analysis?
RAAJMEDI has a Bull Run fundamental score of 69/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does RAAJMEDI belong to?
RAAJMEDI operates in the Packaging industry. This classification helps understand the competitive landscape and sector-specific trends affecting Raaj Medisafe India Ltd.
What is Return on Equity (ROE) and why is it important for RAAJMEDI?
RAAJMEDI has an ROE of 32.48%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Raaj Medisafe India Ltd generates profits from shareholders' equity.
How is RAAJMEDI's debt-to-equity ratio and what does it indicate?
RAAJMEDI has a debt-to-equity ratio of 1.79, which indicates high leverage that increases financial risk. A ratio below 1.0 generally indicates conservative financing.
What is RAAJMEDI's dividend yield and is it a good dividend stock?
RAAJMEDI offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has RAAJMEDI grown over the past 5 years?
RAAJMEDI has achieved 5-year growth rates of: Sales Growth 23.42%, Profit Growth 72.62%, and EPS Growth 47.93%.
What is the promoter holding in RAAJMEDI and why does it matter?
Promoters hold 73.80% of RAAJMEDI shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is RAAJMEDI's market capitalization category?
RAAJMEDI has a market capitalization of ₹91 crores, placing it in the Small-cap category.
How volatile is RAAJMEDI stock?
RAAJMEDI has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for RAAJMEDI?
RAAJMEDI has a 52-week high of ₹N/A and low of ₹N/A.
What is RAAJMEDI's operating profit margin trend?
RAAJMEDI has a 5-year average Operating Profit Margin (OPM) of 14.24%, indicating the company's operational efficiency.
How is RAAJMEDI's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 68.65% and YoY Profit Growth of 78.35%.
What is the institutional holding pattern in RAAJMEDI?
RAAJMEDI has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.